Detecting safety signals in clinical development

How can Pharma companies ensure that they identify safety risks during clinical development?

WCI's Mark Perrott answered just that at the DIA Annual Meeting in Atlanta.

To view Mark's presentation in full please click on the link below:

WCI Consulting Ltd Presentation DIA Annual Meeting June 2007

Should you have any queries or questions then please contact Kate Adams at kate.adams@wcigroup.com or +44 (0) 2392 268133